4-(Azetidin-3-yl)morpholine dihydrochloride, 95.0%, 5g

Sodium Tetrakis[3,5-bis(trifluoromethyl)phenyl]borate>98.0%(HPLC)(W)1g

3-Chloro-4-methoxybenzoic acid, 98.0%, 500g

3-Hydroxy-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzonitrile, 98%, 1g

2-(Methylamino)isonicotinonitrile, 98%, 100mg

Malonic acid, 95.0%, 100g

Methyl 4-methoxy-2-(trifluoromethyl)benzoate, 97%, 1g

Benzyl (1-(tert-butyl)-3-((1S,3R)-3-hydroxycyclopentyl)-1H-pyrazol-5-yl)carbamate, 98%, 1g

[1,1'-biphenyl]-4-yl(2-chloropyridin-4-yl)methanone, 95%, 250mg

TERT-BUTYL 4-(AMINOMETHYL)-5-METHYLAZEPANE-1-CARBOXYLATE, 95.0%, 250mg

1-Phenyl-1H-pyrazol-5-amine, 95.0%, 100g

2-Biphenyl-3',5'-difluoro-carboxylic acid, 97.0%, 1g

Butanedioic acid, compd. with 2-chloro-11-(4-methyl-1-piperazinyl)dibenz[b,f][1,4]oxazepine (1:1), 99%, 50mg